PUBLICATION

Tryptophan residues in TDP-43 and SOD1 modulate the cross-seeding and toxicity of SOD1

Authors
Pokrishevsky, E., DuVal, M.G., McAlary, L., Louadi, S., Pozzi, S., Roman, A., Plotkin, S.S., Dijkstra, A., Julien, J.P., Allison, W.T., Cashman, N.R.
ID
ZDB-PUB-240325-4
Date
2024
Source
The Journal of biological chemistry   300(5): 107207 (Journal)
Registered Authors
Allison, Ted, Duval, Michèle
Keywords
none
MeSH Terms
  • Amyotrophic Lateral Sclerosis*/genetics
  • Amyotrophic Lateral Sclerosis*/metabolism
  • Amyotrophic Lateral Sclerosis*/pathology
  • Animals
  • DNA-Binding Proteins*/genetics
  • DNA-Binding Proteins*/metabolism
  • Humans
  • Motor Neurons/metabolism
  • Motor Neurons/pathology
  • Protein Folding
  • Superoxide Dismutase-1*/chemistry
  • Superoxide Dismutase-1*/genetics
  • Superoxide Dismutase-1*/metabolism
  • Tryptophan*/metabolism
  • Zebrafish*
PubMed
38522514 Full text @ J. Biol. Chem.
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of motor neurons. Neuronal superoxide dismutase-1 (SOD1) inclusion bodies are characteristic of familial ALS with SOD1 mutations, while a hallmark of sporadic ALS is inclusions containing aggregated wild-type TAR DNA-binding protein 43 (TDP-43). We show here that co-expression of mutant or wild-type TDP-43 with SOD1 leads to misfolding of endogenous SOD1 and aggregation of SOD1 reporter protein SOD1G85R-GFP in human cell cultures, and promotes synergistic axonopathy in zebrafish. Intriguingly, this pathological interaction is modulated by natively solvent-exposed tryptophans in SOD1 (tryptophan-32) and TDP-43 RNA-recognition motif RRM1 (tryptophan-172), in concert with natively sequestered TDP-43 N-terminal domain tryptophan-68. TDP-43 RRM1 intrabodies reduce wild-type SOD1 misfolding in human cell cultures, via blocking tryptophan-172. Tryptophan-68 becomes antibody-accessible in aggregated TDP-43 in sporadic ALS motor neurons and cell culture. 5-fluorouridine inhibits TDP-43-induced G85R-GFP SOD1 aggregation in human cell cultures, and ameliorates axonopathy in zebrafish, via its interaction with SOD1 tryptophan-32. Collectively, our results establish a novel and potentially druggable tryptophan-mediated mechanism whereby two principal ALS disease effector proteins might directly interact in disease.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping